Rituximab in immunologic glomerular diseases. - Wikidata - wikimedia - TriplyDB

Rituximab in immunologic glomerular diseases.

Rituximab in immunologic glomerular diseases.

http://www.wikidata.org/entity/Q37989298

about

Non-ischemic cardiomyopathy after rituximab treatment for membranous nephropathy.Rituximab therapy in nephrotic syndrome: implications for patients' management.Adverse events linked with the use of chimeric and humanized anti-CD20 antibodies in children with idiopathic nephrotic syndrome.

P2860

Q33630988-E4612307-1E05-4079-83E5-81AFF0DFF4AB Q38075787-7F267A7B-0BD3-491A-A0AF-96106BA935DF Q50047399-F3C5F282-CD0C-422B-909C-9A5A0E11CA04

P2860

Rituximab in immunologic glomerular diseases.

http://www.wikidata.org/entity/Q37989298

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Rituximab in immunologic glomerular diseases.

@en

Rituximab in immunologic glomerular diseases.

@nl

type

label

Rituximab in immunologic glomerular diseases.

@en

Rituximab in immunologic glomerular diseases.

@nl

prefLabel

Rituximab in immunologic glomerular diseases.

@en

Rituximab in immunologic glomerular diseases.

@nl

P1433

Q37989298-5B15C8FA-10FD-4AA4-8FB6-E425C5D39052

P1476

Q37989298-5B6E8EF5-C8D1-4AB0-86C1-12C560BDE3E3

P2093

Q37989298-3C389D94-D30C-47F2-A527-C54E40932072

Q37989298-7685787B-DF2F-43B4-9A32-2A7154CCF071

Q37989298-8F45EB8E-ABA3-4BB2-ADE4-CB0C7D3E5455

Q37989298-C9B9D98A-D0F1-4C24-8CEC-7F1C38DD69CA

P2860

Q37989298-00273AEB-7F97-4B77-AF29-508B484AA0AE

Q37989298-003DBD63-0C40-4647-8897-1B3B3E52A13F

Q37989298-050E4E24-D768-469E-ADAA-BD326758B308

Q37989298-0560CC47-4E12-492B-9C06-08903645FE56

Q37989298-06AAC39A-D8AD-440D-BE12-595D15E17DB3

Q37989298-06E74FFA-9626-422B-AF57-402973D73FE2

Q37989298-0F034300-5A52-4735-9740-18FA5CCF8920

Q37989298-154A5A6C-745C-4780-AAD3-67CB72090E81

Q37989298-15EA552B-E0C0-45AE-9E55-B8332709363C

Q37989298-1D8A7864-AA97-4334-A35D-0F4754530C2B

P304

Q37989298-82C9A427-4341-4FFA-AA0D-8E00B51920D2

P31

Q37989298-22B134B1-ABEF-476F-B54A-4CABC20E815E

P356

Q37989298-47316F2A-B6BB-411A-B1C1-7D5EAE305E0C

P433

Q37989298-E278FDB4-B7D7-464E-8F86-5B368C84266A

P478

Q37989298-B5C375EE-73C6-4B13-BFBF-8F3C654D2456

P577

Q37989298-17CA60D5-5B97-4B0E-9B2F-D16E48A5BE27

P5875

Q37989298-E2DA5D4F-2048-4604-ACD8-99B2EA4148A9

P698

Q37989298-92E0E234-C1ED-4867-84ED-639D08444FAF

P932

Q37989298-B13D7762-2E1C-471B-9C7E-B3F9BB683D99

P356

P1433

Monoclonal Antibodies

P1476

Rituximab in immunologic glomerular diseases.

@en

P2093

A Ahsan Ejaz

http://www.w3.org/2001/XMLSchema#string

Abdo Asmar

http://www.w3.org/2001/XMLSchema#string

Mourad M Alsabbagh

http://www.w3.org/2001/XMLSchema#string

Nasimul Ahsan

http://www.w3.org/2001/XMLSchema#string

P2860

M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy

Transfection of the CD20 cell surface molecule into ectopic cell types generates a Ca2+ conductance found constitutively in B lymphocytes

Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets

Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis.

Rituximab treatment in hepatitis C infection: an in vitro model to study the impact of B cell depletion on virus infectivity.

Successful treatment of severe thrombotic thrombocytopenic purpura with the monoclonal antibody rituximab.

Rituximab therapy for refractory thrombotic thrombocytopenic purpura.

Change of the course of steroid-dependent nephrotic syndrome after rituximab therapy.

Thrombotic thrombocytopenic purpura associated with renal failure after autologous transplantation for multiple myeloma successfully treated with rituximab.

Serum sickness with an elevated level of human anti-chimeric antibody following treatment with rituximab in a child with chronic immune thrombocytopenic purpura.

P304

198-207

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/MABS.4.2.19286

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2012-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221873425

http://www.w3.org/2001/XMLSchema#string

P698

22377738

http://www.w3.org/2001/XMLSchema#string

P932

3361655

http://www.w3.org/2001/XMLSchema#string